Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction.
Latigo Biotherapeutics stock last closed at $18.52, down 0.22% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Latigo Biotherapeutics stock is currently +7.55% from its 52-week low of $17.22, and -17.58% from its 52-week high of $22.47.
How to Buy Latigo Biotherapeutics Stock
Wondering how to invest in Latigo Biotherapeutics stock? Here's how.
Decide where to buy Latigo Biotherapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Latigo Biotherapeutics stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Pick your method of payment and add your details.
Research Latigo Biotherapeutics stock: The Latigo Biotherapeutics ticker symbol is LTGO. Is Latigo Biotherapeutics stock a good investment? Should you buy shares of LTGO? How do LTGO's underlying business fundamentals look? Do top analysts think Latigo Biotherapeutics is a good buy? Why has LTGO's stock price moved recently? (Hint: Our stock market analysis website can help you understand if LTGO is a good stock to buy).
Make your LTGO buy order: Decide if you will purchase LTGO shares at the current market price or use a limit order to buy LTGO shares at a specific price.
Get updates on your LTGO position: Create a watchlist to important updates regarding your position in Latigo Biotherapeutics stock.
Step 1: Decide where to buy Latigo Biotherapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy LTGO stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Tech to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal information so you can invest in LTGO today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Latigo Biotherapeutics stock
After you have selected the best place to buy Latigo Biotherapeutics stock, it's important to analyze their stock before you buy, so you truly understand the risk as well as the opportunity.
Latigo Biotherapeutics shares quick numbers
LTGO Price
$18.52
1w %
1.48%
1y %
N/A
5y %
N/A
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
N/A
Next Earnings
N/A
Next Dividend
N/A
Latigo Biotherapeutics Due Diligence Checks
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis.
There are more short-term assets than long-term liabilities on the LTGO balance sheet.
There are more short-term assets than short-term liabilities on the LTGO balance sheet.
Negative Financial Indicators:
Total LTGO debt is still negative.
LTGO debt to equity ratio of -0.06 is negative.
Are LTGO executives and large shareholders buying or selling the stock?
In the past 12 months, executives and large shareholders at LTGO have bought more shares than they have sold.
Foresite Capital Management V LLC, 10% Owner of LTGO, was the latest LTGO insider to buy. They bought $2,520,000.00 worth of LTGO stock on Aug 10, 2026.
No, Latigo Biotherapeutics doesn't provide an income stream by paying out dividends.
LTGO Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your LTGO buy order
You have two main options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly the easiest way to buy.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a given price, use a limit order.
Hit the Open Trade button and eToro will place your order.
If you need additional info about investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Latigo Biotherapeutics share?
As of Aug 11, 2026, it costs $18.52 to buy one share of Latigo Biotherapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $9, you can buy 0.486 shares of LTGO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.